Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Dr. Reddy’s intros Prometrium generic
HYDERABAD, India and PRINCETON, N.
Trump Is Said to Seek Cutting Corporate Tax Rate to 15 Percent
WASHINGTON — President Trump has instructed his advisers to make cutting the corporate tax rate to 15 percent a centerpiece of his tax-cut blueprint to be unveiled this week, according to people wit...
Spermidine in Foods Such As Aged Cheese Prevents Liver Damage and Extends Life — in Mice
MedicalResearch.
Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Demonstrated Superior Progression-Free Survival at Interim Analysis
INDIANAPOLIS, IN, USA I April 24, 2017 I Eli Lilly and Company (NYSE.
FDA Approves Renflexis (infliximab-abda), a Biosimilar to Remicade
April 21, 2017 -- FDA today approved Renflexis (infliximab-abda) for multiple indications.
Becton Dickinson to acquire Bard for $24 billion
U.
Nine new medicines recommended for approval by EMA/CHMP, including four orphans
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended a total of nine new medicines for approval at its April meeting.
Upsher-Smith to sell generics business for $1.05B
MAPLE GROVE, Minn.
Teva simultaneously launches AirDuo RespiClick and its authorized generic
JERUSALEM — Teva Pharmaceutical Industries on Thursday announced the simultaneous launch of AirDuo RespiClick (fluticasone propionate and salmeterol) inhalation powder and its authorized gen...
Study demonstrates the efficacy of an investigational treatment in hepatitis C subgroup
Study results presented today demonstrate that the oral, once-daily treatment regimen of glecaprevir/pibrentasvir (G/P) resulted in 95% sustained virologic response rates at 12 weeks post ...
Knee replacement joints created by 3D printer for first time in breakthrough by US university
Printable synthetic cartilage which can be perfectly shaped to fit a knee joint has been designed by scientists in the US.
UK’s Medical Research Council identifies two drugs with potential in Alzheimer's
Scientists from the UK’s Medical Research Council (MRC) have identified two drugs which have the potential to block a pathway that leads to brain cell death, offering hope for a potential th...
542
543
544
545
546
547
548
549
550
